These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36971558)

  • 21. Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections.
    Birkmann A; Bonsmann S; Kropeit D; Pfaff T; Rangaraju M; Sumner M; Timmler B; Zimmermann H; Buschmann H; Ruebsamen-Schaeff H
    J Med Chem; 2022 Oct; 65(20):13614-13628. PubMed ID: 36202389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acyclovir resistance in herpes simplex viruses: Prevalence and therapeutic alternatives.
    Schalkwijk HH; Snoeck R; Andrei G
    Biochem Pharmacol; 2022 Dec; 206():115322. PubMed ID: 36309081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients.
    Lee YJ; Neofytos D; Kim SJ; Cheteyan L; Huang YT; Papadopoulos EB; Jakubowski AA; Papanicolaou GA
    Transpl Infect Dis; 2018 Dec; 20(6):e12977. PubMed ID: 30120866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
    Voigt S; Hofmann J; Edelmann A; Sauerbrei A; Kühl JS
    Transpl Infect Dis; 2016 Oct; 18(5):791-794. PubMed ID: 27482652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral agents for herpes simplex virus.
    Vere Hodge RA; Field HJ
    Adv Pharmacol; 2013; 67():1-38. PubMed ID: 23885997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors and outcomes of acyclovir-resistant herpes simplex virus infection among hematopoietic cell transplant recipients: case-case-control investigation.
    Patel D; Marchaim D; Marcus G; Gayathri R; Lephart PR; Lazarovitch T; Zaidenstein R; Chandrasekar P
    Clin Transplant; 2014 Jan; 28(1):1-5. PubMed ID: 24033498
    [No Abstract]   [Full Text] [Related]  

  • 27. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.
    Dignani MC; Mykietiuk A; Michelet M; Intile D; Mammana L; Desmery P; Milone G; Pavlovsky S
    Bone Marrow Transplant; 2002 Feb; 29(3):263-7. PubMed ID: 11859400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
    Verdonck LF; Cornelissen JJ; Smit J; Lepoutre J; de Gast GC; Dekker AW; Rozenberg-Arska M
    Bone Marrow Transplant; 1993 Feb; 11(2):177-9. PubMed ID: 8382096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Preclinical Model for Studying Herpes Simplex Virus Infection.
    Tajpara P; Mildner M; Schmidt R; Vierhapper M; Matiasek J; Popow-Kraupp T; Schuster C; Elbe-Bürger A
    J Invest Dermatol; 2019 Mar; 139(3):673-682. PubMed ID: 30414908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicase-primase inhibitor pritelivir for HSV-2 infection.
    Wald A; Corey L; Timmler B; Magaret A; Warren T; Tyring S; Johnston C; Kriesel J; Fife K; Galitz L; Stoelben S; Huang ML; Selke S; Stobernack HP; Ruebsamen-Schaeff H; Birkmann A
    N Engl J Med; 2014 Jan; 370(3):201-10. PubMed ID: 24428466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
    Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
    Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline sensitivity of HSV-1 and HSV-2 clinical isolates and defined acyclovir-resistant strains to the helicase-primase inhibitor pritelivir.
    Field HJ; Huang ML; Lay EM; Mickleburgh I; Zimmermann H; Birkmann A
    Antiviral Res; 2013 Nov; 100(2):297-9. PubMed ID: 24021190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of acyclovir-resistant herpes simplex virus.
    Chilukuri S; Rosen T
    Dermatol Clin; 2003 Apr; 21(2):311-20. PubMed ID: 12757254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
    Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
    Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual infection with polyomavirus BK and acyclovir-resistant herpes simplex virus successfully treated with cidofovir in a bone marrow transplant recipient.
    Andrei G; Fiten P; Goubau P; van Landuyt H; Gordts B; Selleslag D; De Clercq E; Opdenakker G; Snoeck R
    Transpl Infect Dis; 2007 Jun; 9(2):126-31. PubMed ID: 17461998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
    Arnulf B; Chebbi F; Lefrere F; Ait Arkoub Z; Varet B; Fillet AM
    Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes simplex virus infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Lee DH; Zuckerman RA;
    Clin Transplant; 2019 Sep; 33(9):e13526. PubMed ID: 30859647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease.
    Erard V; Wald A; Corey L; Leisenring WM; Boeckh M
    J Infect Dis; 2007 Jul; 196(2):266-70. PubMed ID: 17570114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.